Atsushi Suzuki

Atsushi Suzuki

Auto-generated profile, based on publicly available information

Atsushi Suzuki

Mayo Clinic (United States)

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2025 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
OIOsamu Ikeda
Osamu Ikeda
AKAya Kikuchi
Aya Kikuchi
HTHirofumi Tsuzuki
Hirofumi Tsuzuki
HWHideyuki Watanabe
Hideyuki Watanabe
KOKeiichiro Okuyama
Keiichiro Okuyama
TYTaku Yoshida
Taku Yoshida
Studies of diacylglycerol kinase ζ (DGKζ) in DGKζ knockout mice have revealed its role as an intracellular immune checkpoint in T cells. Although enhancing antitumor immunity by pharmacologic inhibition of DGKζ is desirable, selective DGKζ inhibitors for clinical use remain largely unexplored. In this study, we report a novel, small-molecule DGKζ inhibitor, ASP1570, which is currently under phase 1 development (NCT05083481), and characterize its effect on potential resistance mechanisms against approved immune checkpoint inhibitors in multiple immunosuppressive conditions: not only TGF-β, prostaglandin E2, adenosine, and PD-1 but also cytotoxic T-lymphocyte antigen-4 and T-cell immunoreceptor with Ig and immunoreceptor tyrosine-based inhibitory motif. First, our findings indicated that ASP1570 exhibited an inhibitory effect on the kinase activity of DGKζ. Unexpectedly, we observed that DGKζ protein was degraded in cells treated with ASP1570 in a proteasome-dependent manner. ASP1570 enhanced T-cell activation with increased diacylglycerol downstream signaling and released anergic T cells from their hyporesponsive state. Furthermore, ASP1570 restored T-cell functions suppressed by multiple immunosuppressive signals (TGF-β, prostaglandin E2, adenosine, PD-1, cytotoxic T-lymphocyte antigen-4, and T-cell immunoreceptor with Ig and immunoreceptor tyrosine-based inhibitory motif) and induced tumor growth inhibition in two types of syngeneic mouse models: anti–PD-1 antibody–sensitive MC38 and anti–PD-1 antibody–insensitive B16F1/F10. The antitumor efficacy of ASP1570 was canceled by CD8+ T-cell depletion, indicating that its antitumor effect depends on CD8+ cytotoxic T-cell activation. Collectively, ASP1570 potentially improves antitumor efficacy in both anti–PD-1 therapy–resistant and anti–PD-1 therapy–responsive tumors by overcoming multiple immunosuppressive signals.

1 March 2015 in JACC
Verified
Journal Article
Closed access
ASAtsushi Suzuki
Atsushi Suzuki
KFKoji Fukuzawa
Koji Fukuzawa
TYTomoya Yamashita
Tomoya Yamashita
AYAkihiro Yoshida
Akihiro Yoshida
NSNaoto Sasaki
Naoto Sasaki
KHKen-Ichi Hirata
Ken-Ichi Hirata

22 March 2018
Verified
Conference Paper
Closed access
PDF file
AHAlexander Hasnain
Alexander Hasnain
ASAtsushi Suzuki
Atsushi Suzuki
SWSongyun Wang
Songyun Wang
HKHiroki Konishi
Hiroki Konishi
LNLaura Newman
Laura Newman
SHStephan Hohmann
Stephan Hohmann
Cardiac arrhythmias, a condition in which the heart beats irregularly, are typically treated with drug or cardiac ablation therapy. More recently, external beam ablation therapy has been proposed as a potential approach for treating cardiac arrhythmias. Currently, a significant challenge regarding external beam ablation therapy in the heart is compensation for cardiac motion to ensure precise targeting. Porcine animal models are often used for evaluating image-guided intervention systems for cardiac applications; however, to date there have been relatively few studies evaluating motion in the swine heart. In this study, we model and quantify cardiac motion in the left atrium and left ventricle of three beating porcine hearts by tracking anatomic landmarks across twenty phases of the cardiac cycle from multi-phase computed tomography images. 10 landmarks are tracked for each porcine heart, 5 in the left atrium and 5 in the left ventricle. The mean (std) displacement for the 5 left atrial landmarks is 5.5(3.5) mm in x, 5.0(2.9) mm in y, and 5.6(3.3) mm in z. The mean (std) displacement for the 5 left ventricular landmarks is 7.1(3.8) mm in x, 9.9(5.2) mm in y, and 7.7(3.1) mm in z.

1 August 2021 in Heart Rhythm
Verified
Journal Article
Closed access
KIKimitake Imamura
Kimitake Imamura
JDJannis Dickow
Jannis Dickow
ADAmanda J. Deisher
Amanda J. Deisher
MRMaryam Rettmann
Maryam Rettmann
OYOmar Z. Yasin
Omar Z. Yasin
DPDouglas L. Packer
Douglas L. Packer

15 February 2021
Verified
Conference Paper
Closed access
MRMaryam E. Rettmann
Maryam E. Rettmann
ASAtsushi Suzuki
Atsushi Suzuki
ADAmanda Deisher
Amanda Deisher
SHStephan Hohmann
Stephan Hohmann
KIKimitake Imamura
Kimitake Imamura
DPDouglas Packer
Douglas Packer
SPIE Digital Library Proceedings

18 May 2023 in Heart Rhythm
Verified
Journal Article
Open access
THTatsuhiko Hirao
Tatsuhiko Hirao
KIKimitake Imamura
Kimitake Imamura
ASAtsushi Suzuki
Atsushi Suzuki
SHStephan Hohmann
Stephan Hohmann
JDJannis Dickow
Jannis Dickow
DPDouglas L. Packer
Douglas L. Packer